# Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer

Source: https://onco.cc/trials/nct01086605/  
OnCo record `nct01086605` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Pixantrone in Breast cancer, run by Alliance for Clinical Trials in Oncology, completed.

## Summary

Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer is a phase 2 interventional study registered as NCT01086605 by Alliance for Clinical Trials in Oncology, with 46 participants recorded, started 2010-05 and reaching its primary completion in 2012-01. Interventions recorded: pixantrone dimaleate. Conditions recorded: Breast Cancer.

Linked to the drug Pixantrone because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT01086605
- Phase: 2
- Setting: Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
- Sponsor: Alliance for Clinical Trials in Oncology
- Enrolled: 46

## Sources

- ClinicalTrials.gov NCT01086605: https://clinicaltrials.gov/study/NCT01086605

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/)
- drugs: [Pixantrone](https://onco.cc/drugs/pixantrone/)

---
JSON: https://onco.cc/api/v1/entities/nct01086605.json